{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:37Z","timestamp":1788922237129,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030112"],"award-info":[{"award-number":["82030112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1474900"],"award-info":[{"award-number":["23ZR1474900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1413700"],"award-info":[{"award-number":["24ZR1413700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejmech.2025.117449","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T02:57:39Z","timestamp":1740538659000},"page":"117449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Structure\u2013activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR\/MOR activities"],"prefix":"10.1016","volume":"289","author":[{"given":"Siyuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denggao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoliang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinggen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-3839","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117449_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(21)00391-3","article-title":"The opioid crisis and HIV in the USA: deadly synergies","volume":"397","author":"Hodder","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117449_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the US opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117449_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114361","article-title":"Substance-induced psychosis and cognitive functioning: a systematic review","volume":"308","author":"Gicas","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejmech.2025.117449_bib4","article-title":"Substance use disorders (SUDs) and risk of cardiovascular disease (CVD) and cerebrovascular disease (CeVD): analysis of the nationwide inpatient sample (NIS) database","volume":"15","author":"Patel","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.117449_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103677","article-title":"Prevalence, incidence, deaths, and disability-adjusted life-years of drug use disorders for 204 countries and territories during the past 30 years","volume":"86","author":"Shen","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117449_bib6","article-title":"Prevalence of cerebrovascular accidents among the us population with substance use disorders: a nationwide study","volume":"14","author":"Chelikam","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.117449_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nyas.14349","article-title":"Designer drugs: a medicinal chemistry perspective (II)","volume":"1489","author":"Carroll","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117449_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.emc.2021.04.013","article-title":"New designer drugs","volume":"39","author":"Levine","year":"2021","journal-title":"Emerg. Med. Clin."},{"key":"10.1016\/j.ejmech.2025.117449_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2011.06199.x","article-title":"Designer drugs: a medicinal chemistry perspective","volume":"1248","author":"Carroll","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117449_bib10","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1111\/bph.13190","article-title":"The opioid receptors as targets for drug abuse medication","volume":"172","author":"Noble","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117449_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ejmech.2025.117449_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","author":"Kreek","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117449_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders","volume":"1713","author":"Tejeda","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.117449_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2015.01.001","article-title":"Kappa opioid receptor signaling in the brain: circuitry and implications for treatment","volume":"62","author":"Crowley","year":"2015","journal-title":"Prog. Neuro Psychopharmacol."},{"key":"10.1016\/j.ejmech.2025.117449_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"\u03ba-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2025.117449_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin-\u03ba opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00213-023-06486-5","article-title":"Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys","volume":"241","author":"Zamarripa","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: new directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib19","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s00213-021-05965-x","article-title":"The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats","volume":"238","author":"Zamarripa","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","article-title":"Kappa-opioid inhibition of morphine and cocaine self-administration in rats","volume":"681","author":"Glick","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.117449_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(25)11082-3","article-title":"Modulation of the discriminative stimulus effects of cocaine by mu-opioids and kappa-opioids","volume":"261","author":"Spealman","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117449_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1196\/annals.1316.050","article-title":"Possible pharmacotherapy of the opioid \u03ba receptor agonist for drug dependence","volume":"1025","author":"Hasebe","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117449_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100025","article-title":"Classic and non -classic psychedelics for substance use disorder: a review of their historic, past and current research","volume":"3","author":"Mendes","year":"2022","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.ejmech.2025.117449_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106869","article-title":"Historical perspectives and recent advances in small molecule ligands of selective\/biased\/multi-targeted \u03bc\/\u03b4\/\u03ba opioid receptor (2019-2022)","volume":"141","author":"He","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40473-024-00277-8","article-title":"Therapeutic innovations against opioid tolerance and addiction","volume":"11","author":"Basaran","year":"2024","journal-title":"Curr Behav Neurosci"},{"key":"10.1016\/j.ejmech.2025.117449_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117449_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopsych.2019.08.011","article-title":"Kappa opioid receptors and mu opioid receptors as combined targets for medication development for alcoholism","volume":"86","author":"Zhou","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117449_bib28","article-title":"Mu and kappa opioid receptors and the addictions: rewarding and countermodulatory effects and implications for functional polymorphisms","volume":"27","author":"Kreek","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117449_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","article-title":"Cyclazocine revisited","volume":"21","author":"Archer","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2025.117449_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(83)90045-X","article-title":"Nalmefene decreases meal size, food and water-intake and weight-gain in zucker rats","volume":"19","author":"Mclaughlin","year":"1983","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.ejmech.2025.117449_bib31","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1021\/acschemneuro.2c00526","article-title":"Characterization of a potential KOR\/DOR dual agonist with No apparent abuse liability via a complementary structure-activity relationship study on nalfurafine analogues","volume":"13","author":"Li","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117449_bib32","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1021\/acs.jmedchem.4c00646","article-title":"Systematic structure-activity relationship study of nalfurafine analogues toward development of potentially nonaddictive pain management treatments","volume":"67","author":"Onge","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3565(24)37657-8","article-title":"Effects of opioid agonists on cocaine- and food-maintained responding by rhesus monkeys","volume":"286","author":"Mello","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117449_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-3565(24)36769-2","article-title":"Effects of kappa opioids on cocaine self-administration by rhesus monkeys","volume":"282","author":"Negus","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117449_bib35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.npp.1300105","article-title":"Effects of mixed-action \u03ba\/\u03bc opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys","volume":"28","author":"Bowen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/npp.1993.6","article-title":"The effects of nalbuphine and Butorphanol treatment on cocaine and food self-administration by rhesus-monkeys","volume":"8","author":"Mello","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.108.142802","article-title":"Pharmacological characterization of ATPM [(-)-3-Amino-thiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed \u03ba-agonist and \u03bc-agonist\/-antagonist that attenuates morphine antinociceptive tolerance and Heroin self-administration behavior","volume":"329","author":"Wang","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117449_bib38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/aps.2010.164","article-title":"Effects of ATPM-ET, a novel \u03ba agonist with partial \u03bc activity, on morphine-induced physical dependence and behavior sensitization in mice","volume":"31","author":"Sun","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117449_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejphar.2014.06.045","article-title":"Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with \u03ba agonist and \u03bc agonist\/antagonist activity","volume":"740","author":"Sun","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117449_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2004.12.035","article-title":"BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism","volume":"509","author":"Husbands","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117449_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0091-3057(02)01049-3","article-title":"Effects of \u03b2-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity","volume":"74","author":"Bardo","year":"2003","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.ejmech.2025.117449_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2013.05.027","article-title":"The selective \u03bc opioid receptor antagonist \u03b2-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice","volume":"1522","author":"Kitanaka","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.117449_bib43","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/acschemneuro.9b00038","article-title":"Characterization of 17-CyclopropyInnethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 alpha-(indole-7-carboxamido)morphinan (NAN) as a novel opioid receptor modulator for opioid use disorder treatment","volume":"10","author":"Obeng","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117449_bib44","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00213-020-05473-4","article-title":"Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys","volume":"237","author":"Zamarripa","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.047068","article-title":"Use of irreversible antagonists to determine the relative efficacy of \u03bc-opioids in a pigeon drug discrimination procedure: comparison of \u03b2-funaltrexamine and clocinnamox","volume":"305","author":"Barrett","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117449_bib46","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-020-05592-y","article-title":"Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys","volume":"237","author":"Minervini","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117449_bib47","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1021\/jm4012214","article-title":"Design, synthesis, and biological evaluation of 14-heteroarornatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu\/kappa opioid receptor dual selectivity","volume":"56","author":"Yuan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acschemneuro.6b00321","article-title":"The pharmacological heterogeneity of nepenthone analogs in conferring highly selective and potent kappa-opioid agonistic activities","volume":"8","author":"Li","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117449_bib49","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1021\/acs.jmedchem.9b00857","article-title":"Discovery of a highly selective and potent kappa opioid receptor agonist from N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaines with reduced central nervous system (CNS) side effects navigated by the message-address concept","volume":"62","author":"Xiao","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib50","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1021\/acs.jmedchem.1c01082","article-title":"Discovery of an M-substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaine as a selective, potent, and orally active kappa-opioid receptor agonist with an improved central nervous system safety profile","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib51","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1021\/acs.jmedchem.2c00014","article-title":"SLL-627 is a highly selective and potent kappa opioid receptor (KOR) agonist with an unexpected nonreduction in locomotor activity","author":"Kong","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib52","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1021\/acs.jmedchem.3c02439","article-title":"Discovery of an ortho-substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethano-tetrahydronorthebaine derivative as a selective and potent kappa opioid receptor agonist with subsided sedative effect","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115589","article-title":"Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthone","volume":"258","author":"Kong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib54","first-page":"371","article-title":"Synthesis of the new thebaine derivatives by the Diels-Alder reaction with northebaine","volume":"32","author":"Kim","year":"1988","journal-title":"J. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117449_bib55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2008.02.028","article-title":"LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential","volume":"584","author":"Tao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117449_bib56","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1021\/jm0000665","article-title":"Potent and selective indolomorphinan antagonists of the kappa-opioid receptor","volume":"43","author":"Stevens","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib57","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1021\/jm010158+","article-title":"From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes","volume":"44","author":"Portoghese","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117449_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.encep.2014.10.010","article-title":"Place of the opioid system in biology and treatment of Alcohol Use Disorder","volume":"40","author":"Nubukpo","year":"2014","journal-title":"Encephale"},{"key":"10.1016\/j.ejmech.2025.117449_bib59","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1021\/jm010095v","article-title":"Transformation of a \u03ba-opioid receptor antagonist to a \u03ba-agonist by transfer of a guanidinium group from the 5\u2032- to 6\u2032-position of naltrindole","volume":"44","author":"Sharma","year":"2001","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:09:22Z","timestamp":1762265362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":59,"alternative-id":["S0223523425002144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117449","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure\u2013activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR\/MOR activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117449"}}